Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Serum Laboratory Studies, Stool Test, Breath Test01:30

Serum Laboratory Studies, Stool Test, Breath Test

484
Gastrointestinal (GI) diagnostic studies are pivotal in confirming, ruling out, diagnosing, or staging various diseases, including cancers. Following diagnosis, allocating time for discussions with the patient and providing informational resources is crucial. Diagnostic assessments of the GI tract often occur in outpatient settings like endoscopy suites or GI labs. Preparation for these tests may include dietary restrictions, fasting, liquid bowel preparations, laxatives, enemas, and the...
484
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

34
Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
34
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

242
Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
242
Dysrhythmias V: Evaluating Dysrhythmias01:30

Dysrhythmias V: Evaluating Dysrhythmias

130
Dysrhythmias, also known as arrhythmias, are disturbances in the heart's rhythm that range from benign to life-threatening. A thorough evaluation is crucial for appropriate management and involves a comprehensive medical history, physical examination, and various diagnostic tests.Medical HistorySymptoms: Collect detailed information on palpitations, dizziness, syncope, chest pain, and fatigue. Note their onset, frequency, and triggers.Previous Cardiac Issues: Document any history of heart...
130
Blood Studies for Cardiovascular System I: Cardiac Biomarkers01:20

Blood Studies for Cardiovascular System I: Cardiac Biomarkers

379
Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
379
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy01:30

Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy

443
Various diagnostic tests are employed in the diagnostic process for Inflammatory Bowel Disease (IBD), particularly to differentiate between Crohn's disease and ulcerative colitis.
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
443

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Agreement between relatives of Parkinson's patients and clinical observer in home diary assessments.

Journal of Parkinson's disease·2026
Same author

Overcoming the diagnostic gap in mild cognitive impairment in Parkinson's disease: a pilot study employing a machine learning-/augmented reality-based digital biomarker.

Frontiers in aging neuroscience·2026
Same author

The Effect of Dopaminergic Medication on Impulse Control and Compulsive Behaviour: A Translational Perspective.

Basic & clinical pharmacology & toxicology·2026
Same author

Non-motor fluctuation patterns in dyskinetic patients with advanced Parkinson's disease.

Journal of neural transmission (Vienna, Austria : 1996)·2026
Same author

Challenges of Pain in Parkinson's Disease: Results from the OCEAN Study.

Movement disorders : official journal of the Movement Disorder Society·2026
Same author

Evaluating impulse control disorders in people with Parkinson's disease: agreement and added value of patient and caregiver reports.

Frontiers in neurology·2026

Related Experiment Video

Updated: Sep 27, 2025

Dried Blood Spot Collection of Health Biomarkers to Maximize Participation in Population Studies
07:20

Dried Blood Spot Collection of Health Biomarkers to Maximize Participation in Population Studies

Published on: January 28, 2014

36.7K

Diagnostic work up: Laboratory and biomarkers.

Gustav Cedergren Weber1, Per Odin1

  • 1Division of Neurology, Department of Clinical Sciences Lund, Lund University, Lund, Sweden.

International Review of Neurobiology
|April 10, 2022
PubMed
Summary

Diagnosing sexual dysfunction in Parkinson's disease (PD) involves laboratory tests and biomarkers to identify causes like neural or vascular pathology. Early diagnosis is crucial, and can even suggest differential diagnoses such as Multisystem Atrophy.

Keywords:
BiomarkersComorbidityDiagnosisErectile dysfunctionHypersexualityNeuropathyParkinson's diseaseQuestionariesSexual dysfunctionVasculopathy

More Related Videos

Performing Data Mining And Integrative Analysis Of Biomarker in Breast Cancer Using Multiple Publicly Accessible Databases
07:41

Performing Data Mining And Integrative Analysis Of Biomarker in Breast Cancer Using Multiple Publicly Accessible Databases

Published on: May 17, 2019

9.1K
A Blood-based Test for the Detection of ROS1 and RET Fusion Transcripts from Circulating Ribonucleic Acid Using Digital Polymerase Chain Reaction
10:35

A Blood-based Test for the Detection of ROS1 and RET Fusion Transcripts from Circulating Ribonucleic Acid Using Digital Polymerase Chain Reaction

Published on: April 5, 2018

10.5K

Related Experiment Videos

Last Updated: Sep 27, 2025

Dried Blood Spot Collection of Health Biomarkers to Maximize Participation in Population Studies
07:20

Dried Blood Spot Collection of Health Biomarkers to Maximize Participation in Population Studies

Published on: January 28, 2014

36.7K
Performing Data Mining And Integrative Analysis Of Biomarker in Breast Cancer Using Multiple Publicly Accessible Databases
07:41

Performing Data Mining And Integrative Analysis Of Biomarker in Breast Cancer Using Multiple Publicly Accessible Databases

Published on: May 17, 2019

9.1K
A Blood-based Test for the Detection of ROS1 and RET Fusion Transcripts from Circulating Ribonucleic Acid Using Digital Polymerase Chain Reaction
10:35

A Blood-based Test for the Detection of ROS1 and RET Fusion Transcripts from Circulating Ribonucleic Acid Using Digital Polymerase Chain Reaction

Published on: April 5, 2018

10.5K

Area of Science:

  • Neurology
  • Urology
  • Sexual Medicine

Background:

  • Sexual dysfunction is a common, yet often underdiagnosed, non-motor symptom in Parkinson's disease (PD).
  • Understanding the underlying mechanisms of sexual dysfunction in PD is essential for effective management.
  • Distinguishing between psychogenic and organic causes is critical for appropriate treatment strategies.

Purpose of the Study:

  • To provide a comprehensive overview of diagnostic methods for sexual dysfunction in Parkinson's disease.
  • To highlight the role of laboratory tests, biomarkers, and assessment scales.
  • To emphasize the importance of considering comorbidities and differential diagnoses.

Main Methods:

  • Review of current diagnostic approaches for sexual dysfunction in Parkinson's disease.
  • Discussion of laboratory tests, including biomarker analysis.
  • Exploration of psychometric instruments for quantifying sexual function and dysfunction.
  • Consideration of differential diagnostic procedures, including Multisystem Atrophy (MSA).

Main Results:

  • Various methods are available to determine if sexual dysfunction stems from neural pathology, vascular dysfunction, or other mechanisms.
  • Diagnostic tools can differentiate between psychogenic/functional and organic causes of sexual dysfunction.
  • Biomarkers are increasingly important for diagnosis, understanding etiology, and guiding treatment.
  • Numerous scales and instruments exist for detecting and quantifying sexual hypo- and hyperactivity.

Conclusions:

  • Accurate diagnosis of sexual dysfunction in Parkinson's disease requires a multifaceted approach, integrating clinical assessment, laboratory findings, and biomarker analysis.
  • Early and significant sexual dysfunction may warrant consideration of differential diagnoses, such as Multisystem Atrophy.
  • A thorough diagnostic workup, including assessment of comorbidities, is vital for optimizing patient care and management of sexual dysfunction in Parkinson's disease.